| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Femke Heindryckx | Q100996447 |
| P2093 | author name string | Pär Gerwins | |
| Bhavna Rani | |||
| Natasa Pavlovic | |||
| P2860 | cites work | Serotonin promotes tumor growth in human hepatocellular cancer | Q24297176 |
| CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 | ||
| Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma | Q24556510 | ||
| Platelets mediate cytotoxic T lymphocyte-induced liver damage | Q24604707 | ||
| E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung | Q24647117 | ||
| Inflammation and cancer | Q24649640 | ||
| Platelet Activation: The Mechanisms and Potential Biomarkers | Q26741080 | ||
| The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis | Q26786170 | ||
| Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies | Q27324010 | ||
| Anti-platelet therapy: phosphodiesterase inhibitors | Q27687228 | ||
| A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer | Q28195274 | ||
| Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use | Q28263273 | ||
| Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders | Q28326492 | ||
| A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis | Q28569215 | ||
| Pro-fibrogenic potential of PDGF-D in liver fibrosis | Q28583234 | ||
| Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment. | Q30537821 | ||
| Production of soluble P-selectin by platelets and endothelial cells. | Q33331033 | ||
| Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma | Q33372859 | ||
| Platelets promote liver regeneration in early period after hepatectomy in mice | Q33374517 | ||
| Freeze-dried platelets promote hepatocyte proliferation in mice | Q33377010 | ||
| Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease | Q57983635 | ||
| Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2 | Q59335202 | ||
| Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma | Q59797777 | ||
| The Role of Platelets in the Tumor-Microenvironment and the Drug Resistance of Cancer Cells | Q64246098 | ||
| Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis. | Q64929397 | ||
| The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma. | Q64977842 | ||
| Prevention of experimental hepatic metastasis with thromboxane synthase inhibitor | Q70795597 | ||
| ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice | Q73069453 | ||
| Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma | Q74595261 | ||
| Lysis of tumor cells by natural killer cells in mice is impeded by platelets | Q74650896 | ||
| Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy | Q83809949 | ||
| Mean platelet volume/platelet count ratio in hepatocellular carcinoma | Q84628241 | ||
| Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells | Q84631837 | ||
| Human platelets promote liver regeneration with Kupffer cells in SCID mice | Q85763765 | ||
| Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma | Q86022542 | ||
| Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma | Q87324410 | ||
| Ketanserin, a serotonin 2A receptor antagonist, alleviates ischemia-related biliary fibrosis following donation after cardiac death liver transplantation in rats | Q87419222 | ||
| Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury | Q87912119 | ||
| Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism | Q89170877 | ||
| Aspirin Is Associated With Improved Liver Function After Embolization of Hepatocellular Carcinoma | Q92239930 | ||
| Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B | Q92438593 | ||
| Interruption of platelets and thrombin function as a new approach against liver fibrosis induced experimentally in rats | Q92489148 | ||
| Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer | Q92768065 | ||
| Prognostic value of thrombocytosis in patients undergoing surgery for colorectal cancer with synchronous liver metastases | Q92776125 | ||
| Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome | Q93047866 | ||
| Platelet activation and vascular endothelial growth factor 165 release in hepatocellular cancer | Q33392994 | ||
| Blood platelets and inflammation: their relationship with liver and digestive diseases | Q33394857 | ||
| Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. | Q33402906 | ||
| Thrombocytosis and hepatocellular carcinoma | Q33405280 | ||
| Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro | Q33412956 | ||
| Platelet-related phenotypic patterns in hepatocellular carcinoma patients | Q33416416 | ||
| Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines. | Q33684043 | ||
| Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6 | Q33822598 | ||
| Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis | Q33851416 | ||
| Platelets and cancer: a casual or causal relationship: revisited. | Q34294719 | ||
| Serum tumor markers for detection of hepatocellular carcinoma | Q34501851 | ||
| Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma | Q34549999 | ||
| PDGF and signal transduction in hepatic stellate cells | Q34754831 | ||
| Microparticles from apoptotic platelets promote resident macrophage differentiation. | Q35269888 | ||
| Platelets harness the immune response to drive liver cancer | Q36167520 | ||
| Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. | Q36167647 | ||
| Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations | Q36236676 | ||
| Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. | Q36301071 | ||
| Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance | Q36619756 | ||
| Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model | Q36645546 | ||
| Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a. | Q36697797 | ||
| Platelets in liver transplantation: friend or foe? | Q37200718 | ||
| Aspirin in combination with TACE in treatment of unresectable HCC: a matched-pairs analysis | Q37298338 | ||
| Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma | Q37317457 | ||
| Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids | Q37419931 | ||
| Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis | Q37463744 | ||
| Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding | Q37645070 | ||
| Angiogenesis in chronic liver disease and its complications | Q37809119 | ||
| Platelets and the immune continuum | Q37857647 | ||
| Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. | Q38174455 | ||
| Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever. | Q38176402 | ||
| The role of inflammation and liver cancer | Q38211088 | ||
| Targeting the tumor stroma in hepatocellular carcinoma | Q38366586 | ||
| Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo | Q38465566 | ||
| Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice. | Q51163749 | ||
| Platelets Strongly Induce Hepatocyte Proliferation with IGF-1 and HGF In Vitro. | Q52581058 | ||
| Intra-platelet serotonin in prognosis of tumorigenesis: Friend or foe? | Q52650681 | ||
| Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. | Q53024107 | ||
| Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults. | Q53176915 | ||
| Platelet microparticles reprogram macrophage gene expression and function. | Q53358769 | ||
| Role of platelets on liver regeneration after 90% hepatectomy in mice. | Q53468148 | ||
| VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma. | Q55003892 | ||
| Association Between Aspirin Use and Risk of Hepatocellular Carcinoma | Q57029190 | ||
| Platelets and cancer angiogenesis nexus. | Q38691783 | ||
| Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment | Q38724288 | ||
| Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells | Q39435563 | ||
| Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis | Q39441340 | ||
| Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection | Q39473320 | ||
| Platelets surrounding primary tumor cells are related to chemoresistance | Q39651133 | ||
| Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients | Q39805787 | ||
| New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice | Q40052988 | ||
| Hepatoblastoma, thrombocytosis, and increased thrombopoietin | Q40097483 | ||
| Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release | Q40582473 | ||
| Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma | Q40891354 | ||
| Hepatocellular Carcinoma Extrahepatic Metastasis in Relation to Tumor Size and Alkaline Phosphatase Levels | Q40916200 | ||
| The Effects of Serotonin in Immune Cells | Q41061403 | ||
| The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages | Q41481421 | ||
| Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B. | Q42103755 | ||
| Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation. | Q42199539 | ||
| Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma | Q42259945 | ||
| Hepatic platelet and leukocyte adherence during endotoxemia | Q42883057 | ||
| Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation | Q42975901 | ||
| Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis | Q43053223 | ||
| CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis | Q43159403 | ||
| Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target? | Q44522050 | ||
| Designing a fibrotic microenvironment to investigate changes in human liver sinusoidal endothelial cell function | Q45015551 | ||
| Aggravation of viral hepatitis by platelet-derived serotonin | Q45218233 | ||
| Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma. | Q45863835 | ||
| Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors | Q46148909 | ||
| The effect of amrinone on liver regeneration in experimental hepatic resection model | Q46695883 | ||
| Serotonin drives the acquisition of a profibrotic and anti-inflammatory gene profile through the 5-HT7R-PKA signaling axis. | Q47131270 | ||
| By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma. | Q47878727 | ||
| Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats | Q48043433 | ||
| Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond. | Q50131782 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P577 | publication date | 2019-07-20 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Platelets as Key Factors in Hepatocellular Carcinoma | |
| P478 | volume | 11 |
Search more.